Document is current
Any future updates will be listed below
-
Authors
Shen, Chan
Holguin, Rolfy A. Perez
Schaefer, Eric
Zhou, Shouhao
Belani, Chandra P.
Ma, Patrick C.
Reed, Michael F.
- License Information
-
More Information
Article History
Received: 12 October 2021
Accepted: 21 March 2022
First Online: 9 April 2022
Declarations
:
: The Institutional Review Board approved this retrospective observational study, and all patients in the database had been de-identified. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: Dr. Ma reports grants and/or personal fees from Merck, AstraZeneca, and Apollomics, Bristol-Myers Squibb, Takeda, LOXO, Medimmune, Genentech-Roche, Spectrum, Tesaro, EpicentRx and Incyte; non-financial support from Caris Life Sciences, outside the submitted work. Dr. Belani reports being a Consultant /Advisor for Genentech, outside the submitted work. Dr. Reed reports grants and/or personal fees from Olympus and DaVinci, outside the submitted work. All other authors have no competing/conflict of interest.
